The Next Era of Cardiorenal Care Is Precision Fluid Management

Aug 21, 2026 | Health Tech

Image Source: AI generated (Google Gemini)
Independent Contributor
Written by: Mike McCormick, President and CEO
On behalf of: Nuwellis, Inc.

Medicine has become increasingly specialized over the past several decades, driving tremendous advances in our ability to diagnose and treat complex diseases. Specialists now possess deeper expertise than ever before, allowing clinicians to deliver highly targeted care across nearly every area of medicine. But as healthcare has evolved into a system organized around individual organs and specialties, it has also created an unintended consequence: patients whose conditions span multiple organ systems. These patients don’t always fit neatly within a single specialty or clinical pathway and precision fluid management is one of the areas where that shows most clearly.

Few challenges expose that gap as sharply as the management of fluid overload across the cardiorenal continuum.

The heart and kidneys function in constant partnership, working together to regulate fluid balance, blood pressure, and overall physiological stability. When that balance is disrupted, the consequences can be rapid and far-reaching, particularly in acute and critical care environments.

A decision made to support the heart can affect the kidneys, and a decision made to protect kidney function can influence cardiovascular stability. Yet we still often manage fluid through the lens of individual specialties rather than as a shared clinical challenge.

I believe we need to think about fluid management differently. As healthcare increasingly embraces precision medicine, multidisciplinary collaboration, and data-driven care, we have an opportunity to identify fluid overload earlier, better understand how patients are responding to treatment, and intervene more precisely when needed. That is what precision fluid management means to me, and I believe it will be an increasingly important part of the future of cardiorenal care.

Understanding the Role of Fluid in Cardiorenal Care

The relationship between the heart and kidneys is remarkably complex. The heart relies on healthy kidneys to regulate blood volume, electrolyte balance, and vascular resistance. Likewise, the kidneys depend on adequate cardiac output to maintain filtration and remove waste. Together, they work continuously to preserve the body’s internal equilibrium.

When either system begins to deteriorate, however, fluid balance can quickly become destabilized. Excess fluid accumulation contributes to pulmonary congestion, peripheral edema, respiratory distress, and hemodynamic instability. At the same time, overly aggressive fluid removal can compromise kidney function or reduce perfusion to vital organs.

Managing this balance requires more than simply removing excess fluid. It demands precision, understanding when to intervene, how much fluid to remove, and how therapy should adapt as a patient’s condition evolves and responds to treatment.

Heart failure remains one important and well-recognized example of how fluid overload drives disease progression and hospitalization. But it represents only one part of a much broader clinical reality. Fluid management plays a central role across a wide range of conditions, particularly in pediatric and critical care settings where even relatively small changes in fluid balance can have significant consequences.

The Limits of Fragmented Care

Historically, healthcare has organized treatment around individual specialties. Cardiologists, nephrologists, intensivists, and surgeons each bring essential expertise to patient care. This model has delivered meaningful progress, but it can also introduce challenges when treatment decisions affecting fluid balance are made in isolation.

For example, interventions designed to relieve fluid overload may impact kidney function, while efforts to preserve renal function may constrain options for stabilizing cardiovascular status. Without coordinated decision-making, clinicians may find themselves balancing competing priorities rather than pursuing a coordinated approach to managing the patient.

This dynamic is especially pronounced in intensive care units and post-surgical environments, where patients often experience rapid shifts in fluid status and organ function. In these settings, fragmented approaches can increase complexity at precisely the moment when clarity and coordination are most critical.

We need a more integrated approach to cardiorenal care, one that recognizes the relationship between the heart and kidneys and allows clinicians to make more coordinated decisions about fluid management.

Moving Toward a Precision Continuum of Care

Precision fluid management begins with recognizing that care extends across a continuum, not just isolated clinical events.

Patients may move through multiple stages of illness, from acute intervention in the ICU to recovery and long-term management. Their fluid status, organ function, and clinical needs evolve throughout this journey, requiring continuous assessment and adaptation. Managing a single episode of fluid imbalance is rarely sufficient; clinicians must consider how each intervention influences the patient’s trajectory over time.

An effective approach therefore emphasizes early identification of patients at risk for deterioration, ongoing evaluation of cardiac and renal status, and therapies that can be tailored as the patient’s condition changes. The goal is to identify fluid overload earlier, understand how the patient is responding to treatment, and intervene more precisely when needed. For many patients, that begins with medical management, often with diuretics, with other therapies considered when fluid overload persists despite an appropriate medical strategy. It also requires close collaboration across specialties, ensuring that decisions are informed by a comprehensive view of the patient rather than a single organ system.

Advances in monitoring technologies are helping to enable this shift. Continuous or near-real-time insights into fluid balance and hemodynamic status allow clinicians to move from reactive care toward more proactive, data-informed decision-making.

Pediatrics and Critical Care Highlight the Need for Precision

The importance of precision fluid management is perhaps most evident in pediatric and critical care settings.

In infants and young children, even modest changes in fluid balance can have significant consequences for cardiovascular stability, kidney function, and respiratory performance. Clinicians must make highly individualized decisions regarding both the timing and rate of therapy, often under rapidly changing conditions.

Similarly, in intensive care environments, including post-cardiac surgery, patients require continuous monitoring and carefully controlled interventions to maintain stability. These scenarios underscore the need for integrated approaches that combine precise therapy with coordinated, multidisciplinary care.

These settings demonstrate why precision matters. Successful fluid management isn’t simply about removing excess fluid. It is about understanding when to intervene, how much fluid to remove, and how the patient is responding throughout treatment.

Technology Alone Is Not Enough

Technological advancements are essential, but they are only part of the solution.

Achieving true integration requires changes in clinical workflows, communication, and collaboration. Hospitals are increasingly developing multidisciplinary care teams and shared protocols that bring together cardiology, nephrology, critical care, and nursing expertise. These efforts recognize that improving outcomes depends as much on coordinated decision-making as it does on individual therapies.

Technology should support, not replace, clinical judgment. The most valuable innovations are those that give care teams better information and better tools to make more informed decisions for their patients.

The Road Ahead

Precision fluid management represents an opportunity to change how we approach cardiorenal care. It starts with identifying fluid overload earlier, understanding how the patient is responding, and giving clinicians the information and treatment options they need to intervene more precisely when appropriate.

The future of cardiorenal medicine will not be defined by isolated advances in any single area. It will be shaped by how effectively clinicians connect data, technology, and multidisciplinary expertise to manage fluid overload with greater precision.

I believe the opportunity ahead is to bring these pieces together, better information, more precise therapies, and closer collaboration among care teams. If we can do that, we can fundamentally improve how patients with fluid overload are managed across the cardiorenal continuum.

 

Author Bio

    Mike McCormick is President and Chief Executive Officer of Nuwellis. He is a seasoned medical technology executive with more than 35 years of leadership experience spanning product development, commercialization, corporate strategy, capital formation, and value creation. Throughout his career, Mike has founded, scaled, and led both public and private medical technology companies, creating value through commercial execution, operational excellence, strategic transactions, and innovation.
    References: None included.
    The author is President and Chief Executive Officer of a company operating in the medical technology sector and therefore has a commercial interest in the subject matter discussed in this article.All content is published for informational purposes only and does not constitute medical, legal, or investment advice. For more information, see our Terms and Conditions

    Articles that may be of interest

    Rethinking Biomedical Research in the Age of AI

    Rethinking Biomedical Research in the Age of AI

    The paradox of modern biomedical research Biomedical research has never generated so much knowledge, and researchers have never struggled so much to keep pace with it. PubMed now indexes more than 40 million references drawn from roughly 26,000 journals[1]....

    read more

    Articles that may be of interest

    Rethinking Biomedical Research in the Age of AI

    Rethinking Biomedical Research in the Age of AI

    The paradox of modern biomedical research Biomedical research has never generated so much knowledge, and researchers have never struggled so much to keep pace with it. PubMed now indexes more than 40 million references drawn from roughly 26,000 journals[1]....

    read more